Patent · US Active

Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same

US7893106B2 · kind B2 · utility

5Cited by
13References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2007
Grant dateFeb 22, 2011
Priority date
Expiry dateJan 31, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P7/6472
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are novel oxylipins that are derived from γ-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3), and methods of making and using such oxylipins. Also disclosed is the use of such oxylipins in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. Also disclosed are The invention novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of SDA- and/or GLA-derived oxylipins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.